On January 15, 2016, The U.S. Food and Drug Administration released Draft Guidance on Postmarket Management of […]
If you’re in Europe in late September and early October, there are a handful of conferences for […]
We had a full track of Cavalry-esque presentations at SOURCE Boston, and all of the keynotes ended […]